| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 21.2 | 23.7 | 22.3 |
| Other income | 0.8 | 0.2 | 0.4 |
| Total income | 21.9 | 23.9 | 22.7 |
| Profit before exceptional items & tax | -2.4 | 0.1 | 0.9 |
| Exceptional items | -0.1 | 0.0 | 0.0 |
| Profit before tax | -2.5 | 0.1 | 0.9 |
| Net profit | -2.4 | -0.0 | 0.1 |
| Operating margin | -11.4% | 0.4% | 4.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -4.90% |
|---|
NSE results filing, NSE: MAITREYA. Figures extracted from the filing.
Maitreya Medicare Ltd: key numbers
- Share price
- ₹113.50
- Market cap
- ₹76.91 Cr
- Revenue (annual)
- ₹44.85 Cr
- Net profit (annual)
- ₹-2.47 Cr
- P/E (TTM)
- -31.2×Sector 34.2×
- Promoter holding
- 73.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Maitreya Medicare Ltd
All →Maitreya Medicare Annual General Meeting
Maitreya Medicare Limited held its 07th Annual General Meeting on September 21, 2026. The meeting discussed the adoption of financial statements and a director's re-appointment.
Maitreya Medicare Annual General Meeting
Maitreya Medicare Limited approved the scheduling of its 7th Annual General Meeting for September 21, 2026. The board also approved the Director's report and appointed a scrutinizer.
Maitreya Medicare Fund Raise of ₹14.89 Cr
Maitreya Medicare Limited reported zero deviation in the utilization of its ₹14.89 Crore IPO proceeds. Funds were deployed toward subsidiary investments, debt redemption, and working capital.
- Value
- ₹14.89 Cr
Maitreya Medicare Management Change
Maitreya Medicare Limited re-appointed JDM and Associates LLP as Secretarial Auditors for FY 2026-27. This move ensures continued regulatory compliance and statutory oversight.
- Execution
- Financial Year 2026-27
Maitreya Medicare Board Meeting Outcome
Maitreya Medicare appointed R P V & Company as Internal Auditor and re-appointed JDM and Associates as Secretarial Auditor. Both appointments carry 12-month terms.
- Execution
- 12 months
Maitreya Medicare Financial Results
Maitreya Medicare Limited approved its audited standalone and consolidated financial results for the year ended March 31, 2026. The Board also approved auditor re-appointments and preference share redemptions.